Literature DB >> 23607838

Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis.

Sarath C Ranganathan1, Billy Skoric, Kay A Ramsay, Rosemary Carzino, Anne-Marie Gibson, Emily Hart, Jo Harrison, Scott C Bell, Timothy J Kidd.   

Abstract

RATIONALE: Risk of infection with Pseudomonas aeruginosa in cystic fibrosis (CF) may be associated with environmental factors.
OBJECTIVES: To determine whether residential location is associated with risk of first acquisition of P. aeruginosa.
METHODS: We performed bronchoalveolar lavage and upper airway cultures in children newly diagnosed with CF to identify infection with P. aeruginosa during infancy and early childhood. Children were assessed according to their residence in a regional or metropolitan area. Multilocus sequence typing was used to determine P. aeruginosa genotype. An environmental questionnaire was also administered.
MEASUREMENTS AND MAIN RESULTS: A total of 105 of 120 (87.5%) infants diagnosed with CF were included in this study. Diagnosis in 65 infants (61.9%) followed newborn screening at mean age of 4.6 weeks. Sixty subjects (57.1%) were homozygous ΔF508, and 47 (44.8%) were female. Fifty-five (52.3%) infants were regional, of whom 26 (47.3%), compared with 9 of 50 (18.0%) metropolitan children, acquired infection with P. aeruginosa (odds ratio, 4.084; 95% confidence interval, 1.55-11.30). Age at acquisition was similar (regional: median, 2.31 yr; range, 0.27-5.96 yr; metropolitan: median, 3.10 yr, range, 0.89-3.70 yr). Strain typing identified P. aeruginosa genotypes often encountered in different ecological settings and little evidence of cross-infection. Ninety questionnaires (85.7%) were completed. Those who acquired P. aeruginosa were more likely to be living in a household that used water sprinkler systems (P = 0.032), but no differences were identified to explain increased risk of acquisition of P. aeruginosa in regional children.
CONCLUSIONS: Geographical difference in residence of children with CF was associated with increased risk of first acquisition of P. aeruginosa, usually with strains associated with the environment rather than with cross-infection.

Entities:  

Mesh:

Year:  2013        PMID: 23607838     DOI: 10.1513/AnnalsATS.201209-077OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  12 in total

1.  The Pseudomonas aeruginosa Population among Cystic Fibrosis Patients in Quebec, Canada: a Disease Hot Spot without Known Epidemic Isolates.

Authors:  Julie Jeukens; Luca Freschi; Irena Kukavica-Ibrulj; Jean-Guillaume Emond-Rheault; Christian Allard; Jean Barbeau; André Cantin; Steve J Charette; Eric Déziel; François Malouin; Julie Milot; Dao Nguyen; Clara Popa; Brian Boyle; Roger C Levesque
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

2.  Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.

Authors:  Meghan E McGarry; John M Neuhaus; Dennis W Nielson; Ngoc P Ly
Journal:  Pediatr Pulmonol       Date:  2019-05-29

Review 3.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

Review 4.  Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?

Authors:  Sarath C Ranganathan; Graham L Hall; Peter D Sly; Stephen M Stick; Tonia A Douglas
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

5.  Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.

Authors:  Kay A Ramsay; Claire A Butler; Stuart Paynter; Robert S Ware; Timothy J Kidd; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

6.  Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis.

Authors:  Joseph M Collaco; Karen S Raraigh; Lawrence J Appel; Garry R Cutting
Journal:  J Cyst Fibros       Date:  2016-06-11       Impact factor: 5.482

7.  Chronic infection phenotypes of Pseudomonas aeruginosa are associated with failure of eradication in children with cystic fibrosis.

Authors:  P Vidya; L Smith; T Beaudoin; Y C Yau; S Clark; B Coburn; D S Guttman; D M Hwang; V Waters
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01       Impact factor: 3.267

Review 8.  The Pseudomonas aeruginosa AlgZR two-component system coordinates multiple phenotypes.

Authors:  Yuta Okkotsu; Alexander S Little; Michael J Schurr
Journal:  Front Cell Infect Microbiol       Date:  2014-06-20       Impact factor: 5.293

Review 9.  Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail Formulation.

Authors:  Andrew Vaitekenas; Anna S Tai; Joshua P Ramsay; Stephen M Stick; Anthony Kicic
Journal:  Antibiotics (Basel)       Date:  2021-02-02

10.  Respiratory infection rates differ between geographically distant paediatric cystic fibrosis cohorts.

Authors:  Kathryn A Ramsey; Emily Hart; Lidija Turkovic; Marc Padros-Goossens; Stephen M Stick; Sarath C Ranganathan
Journal:  ERJ Open Res       Date:  2016-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.